(PRVL) |
| 0 (0%) 05-31 09:50 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.01 |
| Resistance 1: | 1.93 |
| Pivot price: | 1.93 |
| Support 1: | 1.80 |
| Support 2: | 1.50 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.110 |
| Book Value | 1.180 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.144 |
| Profit Margin (%) | 74.22 |
| Operating Margin (%) | 94.98 |
| Return on Assets (ttm) | 5.9 |
| Return on Equity (ttm) | 8.5 |
Company news
Mon, 24 Nov 2025
Americans Will Be Able to Buy A Protein Powder Made from Air in 2026 - Green Queen Media
Thu, 20 Nov 2025
Pothos to debut Solein-powered protein powders in the US - Nutrition Insight
Fri, 23 Aug 2024
Yong Dai Net Worth (2026) - GuruFocus
Thu, 10 Nov 2022
Asa Abeliovich Net Worth (2026) - GuruFocus
Sun, 18 Jul 2021
Prevail Therapeutics Announces Pricing of Initial Public Offering - IPO Edge
Fri, 22 Jan 2021
Lilly Completes Acquisition of Prevail Therapeutics - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
